Reference Source

Across Co., Ltd · 89-08 · KOREA (THE REPUBLIC OF)

For Across Co., Ltd, import alert is 89-08; country is KOREA (THE REPUBLIC OF); import alert name is "Detention Without Physical Examination of Devices without Approved PMA's or IDE's and Other Devices Not Substantially Equivalent or Without a 510(k)"; product is REVOLAX | REVOLAX | REVOLAX; product code is 60 Q - - 40 Lidocaine HCl (Anesthetic) | 79 L - - MH Implant, Dermal, Collagen for Aesthetic Use | 87 M - - OZ Acid, hyaluronic, intraarticular; date published is 08/22/2022; address is 3F, 23, Geodudanji 1-gil , Dongnae-myeon , Chuncheon-si, Gangwon-do KOREA (THE REPUBLIC OF), verified against its source on 2026-09-30.

Firm
Across Co., Ltd verified
Import alert
89-08
Import alert name
"Detention Without Physical Examination of Devices without Approved PMA's or IDE's and Other Devices Not Substantially Equivalent or Without a 510(k)"
Country
KOREA (THE REPUBLIC OF) verified
Address
3F, 23, Geodudanji 1-gil , Dongnae-myeon , Chuncheon-si, Gangwon-do KOREA (THE REPUBLIC OF) verified
Date published
08/22/2022 verified
Product code
60 Q - - 40 Lidocaine HCl (Anesthetic) | 79 L - - MH Implant, Dermal, Collagen for Aesthetic Use | 87 M - - OZ Acid, hyaluronic, intraarticular each item verified
Product
REVOLAX | REVOLAX | REVOLAX each item verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Across Co., Ltd Date Published : 08/22/2022 3F, 23, Geodudanji 1-gil , Dongnae-myeon , Chuncheon-si, Gangwon-do KOREA (THE REPUBLIC OF)

— accessdata.fda.gov, retrieved 2026-09-15

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

Product code and Product

60 Q - - 40 Lidocaine HCl (Anesthetic) Date Published: 08/22/2022 Desc: REVOLAX 79 L - - MH Implant, Dermal, Collagen for Aesthetic Use Date Published: 08/22/2022 Desc: REVOLAX 87 M - - OZ Acid, hyaluronic, intraarticular Date Published: 08/22/2022 Desc: REVOLAX

— all from accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.